X, K., J, Z., X, L., W, W., X, J., J, C., . . . X, W. (2022). High TRGV 9 Subfamily Expression Marks an Improved Overall Survival in Patients With Acute Myeloid Leukemia. Frontiers in immunology, 13, 823352. https://doi.org/10.3389/fimmu.2022.823352
Chicago Style (17th ed.) CitationX, Kong, Zheng J, Liu X, Wang W, Jiang X, Chen J, Lai J, Jin Z, and Wu X. "High TRGV 9 Subfamily Expression Marks an Improved Overall Survival in Patients With Acute Myeloid Leukemia." Frontiers in Immunology 13 (2022): 823352. https://doi.org/10.3389/fimmu.2022.823352.
MLA (9th ed.) CitationX, Kong, et al. "High TRGV 9 Subfamily Expression Marks an Improved Overall Survival in Patients With Acute Myeloid Leukemia." Frontiers in Immunology, vol. 13, 2022, p. 823352, https://doi.org/10.3389/fimmu.2022.823352.